Drugs & Targets Novartis, MEI Pharma. Receive Breakthrough Therapy Designations September 22, 2016Vol.39 No.08
Study Confirms Association Between RFA Burn Time, OS In Patients Receiving ThermoDox September 22, 2016Vol.39 No.08
Two-drug Immunotherapy May Produce Better Survival in Advanced Melanoma September 22, 2016Vol.39 No.08
Abemaciclib Phase III Trial Continues After Interim Efficacy Criteria Not Met September 22, 2016Vol.39 No.08
Tecentriq Demonstrates Increase In Overall NSCLC Survival in Phase III Study September 22, 2016Vol.39 No.08
FreeObituary Hopkins Biologist Saul Sharkis Dies at 72; Studied Blood Stem Cells’ Role in BMT September 16, 2016Vol.42 No.34
FreeObituary John Bailar, Epidemiologist and Critic of War on Cancer, Dies at 83 September 16, 2016Vol.42 No.34By Laura Brawley
